ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global 13-Valent Pneumococcal Conjugate Vaccine Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-24Q15100
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global 13 Valent Pneumococcal Conjugate Vaccine Market Research Report 2023
BUY CHAPTERS

Global 13-Valent Pneumococcal Conjugate Vaccine Market Research Report 2025

Code: QYRE-Auto-24Q15100
Report
June 2025
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Kangtai
Walvax Biotechnology

13-Valent Pneumococcal Conjugate Vaccine Market

The global market for 13-Valent Pneumococcal Conjugate Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for 13-Valent Pneumococcal Conjugate Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for 13-Valent Pneumococcal Conjugate Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of 13-Valent Pneumococcal Conjugate Vaccine include Pfizer, Kangtai, Walvax Biotechnology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for 13-Valent Pneumococcal Conjugate Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 13-Valent Pneumococcal Conjugate Vaccine.
The 13-Valent Pneumococcal Conjugate Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global 13-Valent Pneumococcal Conjugate Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 13-Valent Pneumococcal Conjugate Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of 13-Valent Pneumococcal Conjugate Vaccine Market Report

Report Metric Details
Report Name 13-Valent Pneumococcal Conjugate Vaccine Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • CDC
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Kangtai, Walvax Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of 13-Valent Pneumococcal Conjugate Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of 13-Valent Pneumococcal Conjugate Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the 13-Valent Pneumococcal Conjugate Vaccine Market report?

Ans: The main players in the 13-Valent Pneumococcal Conjugate Vaccine Market are Pfizer, Kangtai, Walvax Biotechnology

What are the Application segmentation covered in the 13-Valent Pneumococcal Conjugate Vaccine Market report?

Ans: The Applications covered in the 13-Valent Pneumococcal Conjugate Vaccine Market report are Hospital, Clinic, CDC

What are the Type segmentation covered in the 13-Valent Pneumococcal Conjugate Vaccine Market report?

Ans: The Types covered in the 13-Valent Pneumococcal Conjugate Vaccine Market report are Vials, Pre-filled

Recommended Reports

Pneumococcal Vaccines

Pediatric & Human Vaccines

Vaccine Technology & Packaging

1 13-Valent Pneumococcal Conjugate Vaccine Market Overview
1.1 Product Definition
1.2 13-Valent Pneumococcal Conjugate Vaccine by Type
1.2.1 Global 13-Valent Pneumococcal Conjugate Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Vials
1.2.3 Pre-filled
1.3 13-Valent Pneumococcal Conjugate Vaccine by Application
1.3.1 Global 13-Valent Pneumococcal Conjugate Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 CDC
1.4 Global 13-Valent Pneumococcal Conjugate Vaccine Market Size Estimates and Forecasts
1.4.1 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue 2020-2031
1.4.2 Global 13-Valent Pneumococcal Conjugate Vaccine Sales 2020-2031
1.4.3 Global 13-Valent Pneumococcal Conjugate Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 13-Valent Pneumococcal Conjugate Vaccine Market Competition by Manufacturers
2.1 Global 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global 13-Valent Pneumococcal Conjugate Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of 13-Valent Pneumococcal Conjugate Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of 13-Valent Pneumococcal Conjugate Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of 13-Valent Pneumococcal Conjugate Vaccine, Product Type & Application
2.7 Global Key Manufacturers of 13-Valent Pneumococcal Conjugate Vaccine, Date of Enter into This Industry
2.8 Global 13-Valent Pneumococcal Conjugate Vaccine Market Competitive Situation and Trends
2.8.1 Global 13-Valent Pneumococcal Conjugate Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest 13-Valent Pneumococcal Conjugate Vaccine Players Market Share by Revenue
2.8.3 Global 13-Valent Pneumococcal Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global 13-Valent Pneumococcal Conjugate Vaccine Market Scenario by Region
3.1 Global 13-Valent Pneumococcal Conjugate Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global 13-Valent Pneumococcal Conjugate Vaccine Sales by Region: 2020-2031
3.2.1 Global 13-Valent Pneumococcal Conjugate Vaccine Sales by Region: 2020-2025
3.2.2 Global 13-Valent Pneumococcal Conjugate Vaccine Sales by Region: 2026-2031
3.3 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue by Region: 2020-2031
3.3.1 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue by Region: 2020-2025
3.3.2 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue by Region: 2026-2031
3.4 North America 13-Valent Pneumococcal Conjugate Vaccine Market Facts & Figures by Country
3.4.1 North America 13-Valent Pneumococcal Conjugate Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2020-2031)
3.4.3 North America 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe 13-Valent Pneumococcal Conjugate Vaccine Market Facts & Figures by Country
3.5.1 Europe 13-Valent Pneumococcal Conjugate Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2020-2031)
3.5.3 Europe 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific 13-Valent Pneumococcal Conjugate Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific 13-Valent Pneumococcal Conjugate Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific 13-Valent Pneumococcal Conjugate Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific 13-Valent Pneumococcal Conjugate Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America 13-Valent Pneumococcal Conjugate Vaccine Market Facts & Figures by Country
3.7.1 Latin America 13-Valent Pneumococcal Conjugate Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2020-2031)
3.7.3 Latin America 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa 13-Valent Pneumococcal Conjugate Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa 13-Valent Pneumococcal Conjugate Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global 13-Valent Pneumococcal Conjugate Vaccine Sales by Type (2020-2031)
4.1.1 Global 13-Valent Pneumococcal Conjugate Vaccine Sales by Type (2020-2025)
4.1.2 Global 13-Valent Pneumococcal Conjugate Vaccine Sales by Type (2026-2031)
4.1.3 Global 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Type (2020-2031)
4.2 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue by Type (2020-2031)
4.2.1 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue by Type (2020-2025)
4.2.2 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue by Type (2026-2031)
4.2.3 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global 13-Valent Pneumococcal Conjugate Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global 13-Valent Pneumococcal Conjugate Vaccine Sales by Application (2020-2031)
5.1.1 Global 13-Valent Pneumococcal Conjugate Vaccine Sales by Application (2020-2025)
5.1.2 Global 13-Valent Pneumococcal Conjugate Vaccine Sales by Application (2026-2031)
5.1.3 Global 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Application (2020-2031)
5.2 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue by Application (2020-2031)
5.2.1 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue by Application (2020-2025)
5.2.2 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue by Application (2026-2031)
5.2.3 Global 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global 13-Valent Pneumococcal Conjugate Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer 13-Valent Pneumococcal Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer 13-Valent Pneumococcal Conjugate Vaccine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Kangtai
6.2.1 Kangtai Company Information
6.2.2 Kangtai Description and Business Overview
6.2.3 Kangtai 13-Valent Pneumococcal Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Kangtai 13-Valent Pneumococcal Conjugate Vaccine Product Portfolio
6.2.5 Kangtai Recent Developments/Updates
6.3 Walvax Biotechnology
6.3.1 Walvax Biotechnology Company Information
6.3.2 Walvax Biotechnology Description and Business Overview
6.3.3 Walvax Biotechnology 13-Valent Pneumococcal Conjugate Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Walvax Biotechnology 13-Valent Pneumococcal Conjugate Vaccine Product Portfolio
6.3.5 Walvax Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 13-Valent Pneumococcal Conjugate Vaccine Industry Chain Analysis
7.2 13-Valent Pneumococcal Conjugate Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 13-Valent Pneumococcal Conjugate Vaccine Production Mode & Process Analysis
7.4 13-Valent Pneumococcal Conjugate Vaccine Sales and Marketing
7.4.1 13-Valent Pneumococcal Conjugate Vaccine Sales Channels
7.4.2 13-Valent Pneumococcal Conjugate Vaccine Distributors
7.5 13-Valent Pneumococcal Conjugate Vaccine Customer Analysis
8 13-Valent Pneumococcal Conjugate Vaccine Market Dynamics
8.1 13-Valent Pneumococcal Conjugate Vaccine Industry Trends
8.2 13-Valent Pneumococcal Conjugate Vaccine Market Drivers
8.3 13-Valent Pneumococcal Conjugate Vaccine Market Challenges
8.4 13-Valent Pneumococcal Conjugate Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Kangtai
Walvax Biotechnology
List of Tables
 Table 1. Global 13-Valent Pneumococcal Conjugate Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global 13-Valent Pneumococcal Conjugate Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global 13-Valent Pneumococcal Conjugate Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global 13-Valent Pneumococcal Conjugate Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market 13-Valent Pneumococcal Conjugate Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of 13-Valent Pneumococcal Conjugate Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of 13-Valent Pneumococcal Conjugate Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of 13-Valent Pneumococcal Conjugate Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of 13-Valent Pneumococcal Conjugate Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global 13-Valent Pneumococcal Conjugate Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 13-Valent Pneumococcal Conjugate Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global 13-Valent Pneumococcal Conjugate Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global 13-Valent Pneumococcal Conjugate Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global 13-Valent Pneumococcal Conjugate Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific 13-Valent Pneumococcal Conjugate Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific 13-Valent Pneumococcal Conjugate Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific 13-Valent Pneumococcal Conjugate Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific 13-Valent Pneumococcal Conjugate Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific 13-Valent Pneumococcal Conjugate Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa 13-Valent Pneumococcal Conjugate Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa 13-Valent Pneumococcal Conjugate Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global 13-Valent Pneumococcal Conjugate Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global 13-Valent Pneumococcal Conjugate Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global 13-Valent Pneumococcal Conjugate Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global 13-Valent Pneumococcal Conjugate Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global 13-Valent Pneumococcal Conjugate Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global 13-Valent Pneumococcal Conjugate Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global 13-Valent Pneumococcal Conjugate Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global 13-Valent Pneumococcal Conjugate Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer 13-Valent Pneumococcal Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer 13-Valent Pneumococcal Conjugate Vaccine Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Kangtai Company Information
 Table 76. Kangtai Description and Business Overview
 Table 77. Kangtai 13-Valent Pneumococcal Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Kangtai 13-Valent Pneumococcal Conjugate Vaccine Product
 Table 79. Kangtai Recent Developments/Updates
 Table 80. Walvax Biotechnology Company Information
 Table 81. Walvax Biotechnology Description and Business Overview
 Table 82. Walvax Biotechnology 13-Valent Pneumococcal Conjugate Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Walvax Biotechnology 13-Valent Pneumococcal Conjugate Vaccine Product
 Table 84. Walvax Biotechnology Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. 13-Valent Pneumococcal Conjugate Vaccine Distributors List
 Table 88. 13-Valent Pneumococcal Conjugate Vaccine Customers List
 Table 89. 13-Valent Pneumococcal Conjugate Vaccine Market Trends
 Table 90. 13-Valent Pneumococcal Conjugate Vaccine Market Drivers
 Table 91. 13-Valent Pneumococcal Conjugate Vaccine Market Challenges
 Table 92. 13-Valent Pneumococcal Conjugate Vaccine Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of 13-Valent Pneumococcal Conjugate Vaccine
 Figure 2. Global 13-Valent Pneumococcal Conjugate Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global 13-Valent Pneumococcal Conjugate Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Vials Product Picture
 Figure 5. Pre-filled Product Picture
 Figure 6. Global 13-Valent Pneumococcal Conjugate Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global 13-Valent Pneumococcal Conjugate Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. CDC
 Figure 11. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global 13-Valent Pneumococcal Conjugate Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global 13-Valent Pneumococcal Conjugate Vaccine Sales (2020-2031) & (K Units)
 Figure 14. Global 13-Valent Pneumococcal Conjugate Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 15. 13-Valent Pneumococcal Conjugate Vaccine Report Years Considered
 Figure 16. 13-Valent Pneumococcal Conjugate Vaccine Sales Share by Manufacturers in 2024
 Figure 17. Global 13-Valent Pneumococcal Conjugate Vaccine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest 13-Valent Pneumococcal Conjugate Vaccine Players: Market Share by Revenue in 13-Valent Pneumococcal Conjugate Vaccine in 2024
 Figure 19. 13-Valent Pneumococcal Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global 13-Valent Pneumococcal Conjugate Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Country (2020-2031)
 Figure 22. North America 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Country (2020-2031)
 Figure 23. United States 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Country (2020-2031)
 Figure 26. Europe 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Region (2020-2031)
 Figure 34. China 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Country (2020-2031)
 Figure 42. Latin America 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa 13-Valent Pneumococcal Conjugate Vaccine Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa 13-Valent Pneumococcal Conjugate Vaccine Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE 13-Valent Pneumococcal Conjugate Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of 13-Valent Pneumococcal Conjugate Vaccine by Type (2020-2031)
 Figure 52. Global Revenue Market Share of 13-Valent Pneumococcal Conjugate Vaccine by Type (2020-2031)
 Figure 53. Global 13-Valent Pneumococcal Conjugate Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of 13-Valent Pneumococcal Conjugate Vaccine by Application (2020-2031)
 Figure 55. Global Revenue Market Share of 13-Valent Pneumococcal Conjugate Vaccine by Application (2020-2031)
 Figure 56. Global 13-Valent Pneumococcal Conjugate Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 57. 13-Valent Pneumococcal Conjugate Vaccine Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global 13 Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Research Report 2024
13 Valent Pneumococcal Polysaccharide Conjugate Vaccine PCV13 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Multivalent Pneumococcal Conjugate Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pneumococcal Polysaccharide Vaccine Market Research Report 2024
Global Pneumococcal 13 valent Conjugate Vaccine Market Research Report 2024
23 valent Pneumococcal Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pneumococcal Conjugate Vaccine PCV Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Streptococcus Pneumoniae Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pneumococcal Vaccine Polyvalent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Streptococcus Pneumoniae Polysaccharide Vaccine Market Research Report 2025
Global Pneumonia Vaccine Market Insights Forecast to 2030
Global Streptococcus Pneumoniae Antibodies Market Research Report 2024
Global Meningococcal Group A and C Conjugate Vaccine Market Research Report 2024
Global Pneumococcal Testing Market Research Report 2024
Global Respiratory Syncytial Virus Vaccine for Children Market Research Report 2024
Meningococcal Disease Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mycoplasma Pneumoniae Antibodies Market Research Report 2024
Global Haemophilus Influenzae Type b Conjugate Vaccine Market Research Report 2025
Global 23 Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2024
Global Vaccines for the Elderly Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions